Jade Biosciences (JBIO) Other Non Operating Income (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Other Non Operating Income data on file, last reported at -$9000.0 in Q1 2026.

• Quarterly Other Non Operating Income changed N/A year-over-year to -$9000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54000.0 (down 96.12% YoY) and the FY2025 annual result came in at $63000.0, up 431.58% from the prior year.
• Other Non Operating Income retreated to -$9000.0 in Q1 2026, from $91000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.8 million in Q4 2022 to a low of -$28000.0 in Q3 2025.
• A 5-year average of $477666.7 and a median of $47500.0 in 2022 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 24942.86% in 2022, down 500.0% in 2022.
• Tracing JBIO's Other Non Operating Income over 5 years: stood at $1.8 million in 2022, then plunged by 99.94% to $1000.0 in 2023, then jumped by 138900.0% to $1.4 million in 2024, then plunged by 93.45% to $91000.0 in 2025, then plunged by 109.89% to -$9000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$9000.0 (Q1 2026), $91000.0 (Q4 2025), and -$28000.0 (Q3 2025), per Business Quant data.